Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales15 06714 57115 94115 30615 63116 563
EBITDA7 1997 6298 0987 6147 6678 184
Operating profit (EBIT)6 9147 2457 6487 3817 5278 065
Pre-Tax Profit (EBT)------
Net income3 683-1 220-4 404-1 152-136817
P/E ratio31,2-66,2-12,4-61,9-57449,5
EPS ( $ )10,0-3,17-13,2-2,80-0,303,50
Dividend per Share ( $ )--2,802,752,783,10
Yield--1,71%1,58%1,60%1,79%
Reference price ( $ )312.5210.01163.58173.39173.39173.39
Announcement Date02/22/2016
12:30pm
02/08/2017
12:00pm
02/06/2018
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt41 62119 54323 62623 17320 04016 307
Finance------
Operating income (EBITDA)7 1997 6298 0987 6147 6678 184
Leverage
(Debt/EBITDA)
5,78x2,56x2,92x3,04x2,61x1,99x
Capital Expenditure455331350324339338
Book Value Per Share (BVPS)194 $199 $224 $206 $201 $199 $
Cash Flow per Share11,7 $3,64 $16,5 $15,5 $17,3 $19,4 $
Announcement Date02/22/2016
12:30pm
02/08/2017
12:00pm
02/06/2018
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 59 628 M$ -
Entreprise Value (EV) 82 800 M$ 79 667 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS)
Capitalization / Revenue 3,90x 3,81x
EV / Revenue 5,41x 5,10x
EV / EBITDA 10,9x 10,4x
Yield (DPS / Price) 1,58% 1,60%
Price to book (Price / BVPS) 0,84x 0,86x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 48,2% 48,2%
operating Leverage (Delta EBIT / Delta Sales) -0,87x 0,93x
Net Margin (Net Profit / Revenue) -7,53% -0,87%
ROA (Net Profit / Asset) 5,64% 6,02%
ROE (Net Profit / Equities) 7,83% 8,39%
Rate of Dividend -97,9% -920%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,11% 2,17%
Cash Flow / Sales 34,3% 37,5%
Capital Intensity (Assets / Sales) -1,33x -0,14x
Financial Leverage (Net Debt / EBITDA) 3,04x 2,61x
EPS & Dividend